全球呼吸治疗设备市场规模、份额、趋势和成长分析报告（2026-2034）

预计呼吸治疗设备市场将从 2025 年的 20.7 亿美元成长到 2034 年的 34.2 亿美元，2026 年至 2034 年的复合年增长率为 5.72%。

由于慢性呼吸系统疾病的日益普遍，全球呼吸内视镜治疗设备市场正经历显着成长。气喘、慢性阻塞性肺病）和肺癌等疾病在全球呈现上升趋势。空气污染、吸烟率和职业风险因素是造成这些疾病的主要因素。微创支气管镜检查因其恢復时间短而日益受到青睐。医疗机构正在扩大先进呼吸设备的应用范围，以改善患者的治疗效果。

技术创新正在深刻地改变市场格局。机器人辅助支气管镜检查和先进的影像系统提高了诊断准确率。新型设备设计提升了肿瘤定位和切片检查的精准度。医院和专科诊所正大力投资先进的内视镜治疗设备。老年人口的不断增长，以及他们更容易患呼吸系统疾病，进一步推动了市场需求。

发展中地区医疗基础设施的扩建将支持未来的成长。人们对肺部疾病早期检测重要性的认识不断提高，将促使检测数量增加。将人工智慧融入诊断成像技术将提升检测效率。持续的产品研发，旨在减少併发症，将提高产品的普及率。随着呼吸系统健康成为全球医疗保健的重点，市场前景依然强劲。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球呼吸内治疗设备市场：依设备类型划分

• 市场分析、洞察与预测
• 诊断设备
• 治疗设备
• 週边血管介入治疗
• 血管内治疗
• 心
• 介入放射学
• 静脉
• 其他的

第五章 全球呼吸治疗设备市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 诊断中心
• 门诊手术中心

第六章 全球呼吸治疗设备市场：依专科领域划分

• 市场分析、洞察与预测
• 心臟科医生
• 放射科医生
• 血管外科医师
• 其他的

第七章 全球呼吸治疗设备市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Fujifilm Holdings Corporation
  • Medtronic Plc
  • Johnson & Johnson
  • Smith & Nephew Plc
  • Stryker Corporation
  • Olympus Corporation
  • Hoya Corporation
  • Steris Healthcare
  • Conmed Corporation
  • Boston Scientific Corporation

The Respiratory Endotherapy Devices Market size is expected to reach USD 3.42 Billion in 2034 from USD 2.07 Billion (2025) growing at a CAGR of 5.72% during 2026-2034.

The Global Respiratory Endotherapy Devices Market is witnessing substantial growth due to the increasing burden of chronic respiratory diseases. Conditions such as asthma, chronic obstructive pulmonary disease, and lung cancer are rising globally. Air pollution, smoking prevalence, and occupational hazards are key contributing factors. Minimally invasive bronchoscopic procedures are gaining preference due to shorter recovery times. Healthcare providers are increasingly adopting advanced respiratory devices to improve patient outcomes.

Technological innovation is transforming the market landscape significantly. Robotic-assisted bronchoscopy and enhanced imaging systems are improving diagnostic precision. New device designs are enabling more accurate tumor localization and biopsy procedures. Hospitals and specialty clinics are investing heavily in advanced endotherapy equipment. The growing elderly population, which is more susceptible to respiratory illnesses, is further driving demand.

Future growth will be supported by expanding healthcare infrastructure in developing regions. Increasing awareness about early detection of lung diseases will boost procedural volumes. Integration of artificial intelligence in diagnostic imaging will enhance procedural efficiency. Continuous product development aimed at reducing complications will strengthen adoption rates. The market outlook remains strong as respiratory health becomes a global healthcare priority.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Devices

• Diagnostic Devices
• Therapeutic Devices
• Peripheral Vascular Intervention
• Endovascular Interventions
• Cardiac
• Interventional Radiology
• Venous
• Others

By End User

• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers

By Specialist

• Cardiologists
• Radiologists
• Vascular Surgeons
• Others

COMPANIES PROFILED

• Fujifilm Holdings Corporation, Medtronic plc, Johnson Johnson, Smith Nephew Plc, Stryker Corporation, Olympus Corporation, Hoya Corporation, Steris Healthcare, Conmed Corporation, Boston Scientific Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL RESPIRATORY ENDOTHERAPY DEVICES MARKET: BY DEVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Devices
• 4.2. Diagnostic Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Therapeutic Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Peripheral Vascular Intervention Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Endovascular Interventions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Cardiac Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Interventional Radiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Venous Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RESPIRATORY ENDOTHERAPY DEVICES MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RESPIRATORY ENDOTHERAPY DEVICES MARKET: BY SPECIALIST 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Specialist
• 6.2. Cardiologists Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Radiologists Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Vascular Surgeons Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL RESPIRATORY ENDOTHERAPY DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Devices
  • 7.2.2 By End User
  • 7.2.3 By Specialist
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Devices
  • 7.3.2 By End User
  • 7.3.3 By Specialist
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Devices
  • 7.4.2 By End User
  • 7.4.3 By Specialist
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Devices
  • 7.5.2 By End User
  • 7.5.3 By Specialist
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Devices
  • 7.6.2 By End User
  • 7.6.3 By Specialist
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL RESPIRATORY ENDOTHERAPY DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Fujifilm Holdings Corporation
  • 9.2.2 Medtronic Plc
  • 9.2.3 Johnson & Johnson
  • 9.2.4 Smith & Nephew Plc
  • 9.2.5 Stryker Corporation
  • 9.2.6 Olympus Corporation
  • 9.2.7 Hoya Corporation
  • 9.2.8 Steris Healthcare
  • 9.2.9 Conmed Corporation
  • 9.2.10 Boston Scientific Corporation